Antiviral therapy of chronic hepatitis C complicated by systemic cryoglobulinemic vasculitis

Literature analysis of published data on mechanisms of infection, disease progression and treatment of chronic hepatitis C, associated with systemic cryoglobulinemic vasculitis and kidney involvement is presented. A clinical case of effective treatment of cryoglobulinemic vasculitis associated with...

Full description

Bibliographic Details
Main Authors: N. V. Dunaeva, V. E. Karev, O. A. Vorobyeva, A. V. Mazing, S. V. Lapin, A. V. Smirnov, D. A. Gusev
Format: Article
Language:Russian
Published: Journal Infectology 2016-07-01
Series:Журнал инфектологии
Subjects:
Online Access:https://journal.niidi.ru/jofin/article/view/477
_version_ 1826557910118825984
author N. V. Dunaeva
V. E. Karev
O. A. Vorobyeva
A. V. Mazing
S. V. Lapin
A. V. Smirnov
D. A. Gusev
author_facet N. V. Dunaeva
V. E. Karev
O. A. Vorobyeva
A. V. Mazing
S. V. Lapin
A. V. Smirnov
D. A. Gusev
author_sort N. V. Dunaeva
collection DOAJ
description Literature analysis of published data on mechanisms of infection, disease progression and treatment of chronic hepatitis C, associated with systemic cryoglobulinemic vasculitis and kidney involvement is presented. A clinical case of effective treatment of cryoglobulinemic vasculitis associated with HCV infection is described. Female with HCV infection genotype 1b with liver fibrosis 1 grade Metavir developed clinical picture of essential mixed cryoglobulinemia II type with monoclonal IgM/kappa production. Cryoglobulinemia was presented with skin hemorrhagic vasculitis, proliferative vasculitis of small liver vessels, kidney involvement with III type membranoproliferative glomerulonephritis. Treatment with Dasabuvir;Оmbitasvir+Paritaprevir+Ritonavir without immunosuppressive medications or steroids resulted in persistent virologic response by 12 weeks after administration and also dramatic reduction of cryoglobulimenia from 27% to 8%, suppression of detectable IgM/kappa production, diminished skin vasculitis, restoration of glomerular filtration rate, proteinuria and decrease in erythrocyteuria.
first_indexed 2024-03-12T04:46:05Z
format Article
id doaj.art-89f8e345d0b241d9bd17af5202bed793
institution Directory Open Access Journal
issn 2072-6732
language Russian
last_indexed 2025-03-14T08:36:06Z
publishDate 2016-07-01
publisher Journal Infectology
record_format Article
series Журнал инфектологии
spelling doaj.art-89f8e345d0b241d9bd17af5202bed7932025-03-02T13:00:28ZrusJournal InfectologyЖурнал инфектологии2072-67322016-07-01824047474Antiviral therapy of chronic hepatitis C complicated by systemic cryoglobulinemic vasculitisN. V. Dunaeva0V. E. Karev1O. A. Vorobyeva2A. V. Mazing3S. V. Lapin4A. V. Smirnov5D. A. Gusev6Centers for AIDS and Other Infectious DiseasesScience Research Institute of Children’s InfectionsNational Center of Clinical Morphological DiagnosticsFirst Saint-Petersburg State Medical University named after I.P. PavlovFirst Saint-Petersburg State Medical University named after I.P. PavlovNovgorod State University named after Yaroslav-the-WiseCenters for AIDS and Other Infectious DiseasesLiterature analysis of published data on mechanisms of infection, disease progression and treatment of chronic hepatitis C, associated with systemic cryoglobulinemic vasculitis and kidney involvement is presented. A clinical case of effective treatment of cryoglobulinemic vasculitis associated with HCV infection is described. Female with HCV infection genotype 1b with liver fibrosis 1 grade Metavir developed clinical picture of essential mixed cryoglobulinemia II type with monoclonal IgM/kappa production. Cryoglobulinemia was presented with skin hemorrhagic vasculitis, proliferative vasculitis of small liver vessels, kidney involvement with III type membranoproliferative glomerulonephritis. Treatment with Dasabuvir;Оmbitasvir+Paritaprevir+Ritonavir without immunosuppressive medications or steroids resulted in persistent virologic response by 12 weeks after administration and also dramatic reduction of cryoglobulimenia from 27% to 8%, suppression of detectable IgM/kappa production, diminished skin vasculitis, restoration of glomerular filtration rate, proteinuria and decrease in erythrocyteuria.https://journal.niidi.ru/jofin/article/view/477chronic hepatitis ccryoglobulinemiacryoglobulinemic vasculitisglomerulonephritisparitaprenovirritonavirombitasvirdasabuvir3d therapy
spellingShingle N. V. Dunaeva
V. E. Karev
O. A. Vorobyeva
A. V. Mazing
S. V. Lapin
A. V. Smirnov
D. A. Gusev
Antiviral therapy of chronic hepatitis C complicated by systemic cryoglobulinemic vasculitis
Журнал инфектологии
chronic hepatitis c
cryoglobulinemia
cryoglobulinemic vasculitis
glomerulonephritis
paritaprenovir
ritonavir
ombitasvir
dasabuvir
3d therapy
title Antiviral therapy of chronic hepatitis C complicated by systemic cryoglobulinemic vasculitis
title_full Antiviral therapy of chronic hepatitis C complicated by systemic cryoglobulinemic vasculitis
title_fullStr Antiviral therapy of chronic hepatitis C complicated by systemic cryoglobulinemic vasculitis
title_full_unstemmed Antiviral therapy of chronic hepatitis C complicated by systemic cryoglobulinemic vasculitis
title_short Antiviral therapy of chronic hepatitis C complicated by systemic cryoglobulinemic vasculitis
title_sort antiviral therapy of chronic hepatitis c complicated by systemic cryoglobulinemic vasculitis
topic chronic hepatitis c
cryoglobulinemia
cryoglobulinemic vasculitis
glomerulonephritis
paritaprenovir
ritonavir
ombitasvir
dasabuvir
3d therapy
url https://journal.niidi.ru/jofin/article/view/477
work_keys_str_mv AT nvdunaeva antiviraltherapyofchronichepatitisccomplicatedbysystemiccryoglobulinemicvasculitis
AT vekarev antiviraltherapyofchronichepatitisccomplicatedbysystemiccryoglobulinemicvasculitis
AT oavorobyeva antiviraltherapyofchronichepatitisccomplicatedbysystemiccryoglobulinemicvasculitis
AT avmazing antiviraltherapyofchronichepatitisccomplicatedbysystemiccryoglobulinemicvasculitis
AT svlapin antiviraltherapyofchronichepatitisccomplicatedbysystemiccryoglobulinemicvasculitis
AT avsmirnov antiviraltherapyofchronichepatitisccomplicatedbysystemiccryoglobulinemicvasculitis
AT dagusev antiviraltherapyofchronichepatitisccomplicatedbysystemiccryoglobulinemicvasculitis